Jeffrey Tate - Net Worth and Insider Trading
Jeffrey Tate Net Worth
The estimated net worth of Jeffrey Tate is at least $45,955 dollars as of 2024-11-13. Jeffrey Tate is the COO of Cyclo Therapeutics Inc and owns about 62,101 shares of Cyclo Therapeutics Inc (CYTH) stock worth over $45,955. Details can be seen in Jeffrey Tate's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey Tate has not made any transactions after 2023-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey Tate
Jeffrey Tate Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Tate owns 1 companies in total, including Cyclo Therapeutics Inc (CYTH) .
Click here to see the complete history of Jeffrey Tate’s form 4 insider trades.
Insider Ownership Summary of Jeffrey Tate
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2023-04-20 | director & Chief Executive Officer |
Jeffrey Tate Latest Holdings Summary
Jeffrey Tate currently owns a total of 1 stock. Jeffrey Tate owns 62,101 shares of Cyclo Therapeutics Inc (CYTH) as of April 20, 2023, with a value of $45,955.
Latest Holdings of Jeffrey Tate
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2023-04-20 | 62,101 | 0.74 | 45,955 |
Holding Weightings of Jeffrey Tate
Jeffrey Tate Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey Tate has made a total of 4 transactions in Cyclo Therapeutics Inc (CYTH) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Cyclo Therapeutics Inc is the acquisition of 29,941 shares on April 20, 2023, which cost Jeffrey Tate around $21,258.
Insider Trading History of Jeffrey Tate
- 1
Jeffrey Tate Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey Tate's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Tate is 34.03%. GuruFocus also compares Jeffrey Tate's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Tate within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey Tate's insider trading performs compared to the benchmark.
Performance of Jeffrey Tate
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.09 | | | | | |
| Relative Return to S&P 500(%) | 15.17 | | | | | |
Jeffrey Tate Ownership Network
Ownership Network List of Jeffrey Tate
Ownership Network Relation of Jeffrey Tate
Jeffrey Tate Owned Company Details
What does Cyclo Therapeutics Inc do?
Who are the key executives at Cyclo Therapeutics Inc?
Jeffrey Tate is the director & Chief Executive Officer of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , SVP for Medical Affairs Sharon Hemond Hrynkow , and Chief Medical Officer Lise Lund Kjems .
Cyclo Therapeutics Inc (CYTH) Insider Trades Summary
Over the past 18 months, Jeffrey Tate made no insider transaction in Cyclo Therapeutics Inc (CYTH). Other recent insider transactions involving Cyclo Therapeutics Inc (CYTH) include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,000,000 shares were bought by its insiders, resulting in a net purchase of 4,000,000 shares.
Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclo Therapeutics Inc Insider Transactions
Jeffrey Tate Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey Tate. You might contact Jeffrey Tate via mailing address: C/o Ctd Holdings, Inc., 27317 Nw 78th Avenue, High Springs Fl 32643.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
